ATC Abstracts

American Transplant Congress abstracts

2018 American Transplant Congress » Concurrent Session: CMV: Bench to Bedside

Date: Monday, June 4, 2018

Time: 2:30pm-4:00pm

Location: Room 608/609

Session Type: Concurrent Session

Meeting: 2018 American Transplant Congress

2:30pm-2:42pm
Significant Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to a Standard Tacrolimus-MPA Regimen in De Novo Kidney Transplant Recipients: ATHENA 12 Months Data on Infections

A. Hauser,1 C. Sommerer,1 B. Suwelack,1 D. Dragun,1 O. Witzke,1 C. Hugo,1 N. Kamar,2 P. Merville,2 P. Schenker,1 M. Junge,3 F. Thaiss,1 B. Nashan.1

2:42pm-2:54pm
CMV-Specific Cell-Mediated Immunity after Valgancyclovir Prophylaxis Predicts Late Onset CMV Infection in Kidney Transplant Patients

M. Jarque,1 E. Crespo,1 E. Melilli,2 A. Manonelles,2 N. Montero,2 S. Luque,1 J. Cruzado,1,2 J. Grinyo,1,2 O. Bestard.1,2

2:54pm-3:06pm
Kidney Transplant Allocation with CMV Seromatching Reduces CMV Infection without Affecting Wait Times

A. Narra,1 L. Strasfeld,2 D. Basuli,1 M. Stack,1 E. Langewisch,3 A. Olyaei,1 D. Norman,1,4 J. Lockridge.1,4

3:06pm-3:18pm
The Incidence of Polyomavirus-BK and Cytomegalovirus Infections in Renal Transplant Recipients Following Rituximab Administration

A. Kraljevic, C. D'Agostino, C. Kane, K. Cunningham, A. Shetty, C. Richardson.

3:18pm-3:30pm
Prospective, Multi-Center Observational Study of Cell-Mediated Immunity for Cytomegalovirus Infection in Kidney Transplant Recipients

D. Kumar,1 P. Chin-Hong,2 L. Kayler,3 D. Wojciechowski,4 A. Limaye,5 O. Gaber,6 S. Ball,7 A. Mehta,8 T. Blanchard,9 C. Kotton.4

3:30pm-3:42pm
T-Cell Depletion Does Not Increase the Risk of CMV Infection in Donor-Positive, Recipient-Negative Kidney Transplants Due to the Absence of Preformed CMV-Specific Cell-Mediated Immunity

M. Jarque,1 H. Kaminski,2 L. Couzi,2 E. Crespo,1 J. Déchanet-Merville,3 S. Luque,1 N. Montero,4 M. Pascual,5 O. Manuel,5,6 P. Merville,2 O. Bestard.1,4

3:42pm-3:54pm
CMV Mismatch Still Negatively Affects Patient and Graft Survival in the Era of CMV Prophylactic and Preemptive Therapy: A Paired Kidney Analysis

N. Leeaphorn,1 N. Garg,2 N. Thamcharoen,1 E. Khankin,1 F. Cardarelli,1 M. Pavlakis.1

« View all sessions from the 2018 American Transplant Congress